Ko Kwang-Won, Nam Do-Hyun, Kong Doo-Sik, Lee Jung-Ii, Park Kwan, Kim Jong-Hyun
Department of Neurosurgery, Samsung Medical Center and Samsung Biomedical Research Institute, SungKyunKwan University School of Medicine, 50 Ilwon-Dong, Kangnam-ku, Seoul 135-710, Korea.
J Clin Neurosci. 2007 Aug;14(8):747-53. doi: 10.1016/j.jocn.2006.05.005. Epub 2007 May 17.
We evaluated the relationship between histological malignant subtypes (WHO grade II or III) of meningioma and clinical outcome. Of 485 patients treated surgically for intracranial meningioma at our hospital between 1994 and 2004, 49 (10%; 18 male, 31 female) had potentially malignant features. The histological tumor subtypes within this group of patients included: atypical (n=23); clear cell (n=3); chordoid (n=5); rhabdoid (n=16); and anaplastic (n=4). Correlations among prognosis, recurrence, and the following factors were analyzed for each histological subtype: the Simpson grade of surgical resection (grades I-III vs. grade IV), tumor location (convexity vs. other), the Ki-67 index, and use of postoperative radiotherapy. The median value of the Ki-67 index was 16.2% (range: 1.0-57.2%). The surgical resections were of Simpson grades I-III and IV in 43 and six of the 49 patients, respectively. Tumors recurred after the initial surgical resection in 14 of the 49 patients. In view of the relatively high proportion of malignant subtypes (10%), we suggest that all meningiomas should be evaluated for malignancy. The extent of surgical resection, the histological subtype, and the Ki-67 index can help to predict the clinical outcome for meningioma patients.
我们评估了脑膜瘤的组织学恶性亚型(世界卫生组织二级或三级)与临床结局之间的关系。1994年至2004年间,我院对485例颅内脑膜瘤患者进行了手术治疗,其中49例(10%;男性18例,女性31例)具有潜在恶性特征。该组患者的组织学肿瘤亚型包括:非典型性(n = 23);透明细胞型(n = 3);脊索样型(n = 5);横纹肌样型(n = 16);间变性(n = 4)。针对每种组织学亚型,分析了预后、复发与以下因素之间的相关性:手术切除的辛普森分级(一级至三级与四级)、肿瘤位置(凸面与其他部位)、Ki-67指数以及术后放疗的使用情况。Ki-67指数的中位数为16.2%(范围:1.0 - 57.2%)。49例患者中,43例和6例的手术切除分别为辛普森一级至三级和四级。49例患者中有14例在初次手术切除后复发。鉴于恶性亚型的比例相对较高(10%),我们建议对所有脑膜瘤进行恶性评估。手术切除范围、组织学亚型和Ki-67指数有助于预测脑膜瘤患者的临床结局。